Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;16(6):850-852.
doi: 10.2215/CJN.04150321.

To Add Weight to Overweight

Affiliations
Editorial

To Add Weight to Overweight

Maatje D A van Gastel et al. Clin J Am Soc Nephrol. 2021 Jun.
No abstract available

Keywords: ADPKD; autosomal dominant polycystic kidney disease; body mass index; overweight.

PubMed Disclaimer

Comment on

  • Overweight and Obesity and Progression of ADPKD.
    Nowak KL, Steele C, Gitomer B, Wang W, Ouyang J, Chonchol MB. Nowak KL, et al. Clin J Am Soc Nephrol. 2021 Jun;16(6):908-915. doi: 10.2215/CJN.16871020. Epub 2021 Jun 11. Clin J Am Soc Nephrol. 2021. PMID: 34117082 Free PMC article.

References

    1. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367: 2407–2418, 2012. - PubMed
    1. Enhörning S, Struck J, Wirfält E, Hedblad B, Morgenthaler NG, Melander O: Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 96: E1065–E1072, 2011. - PubMed
    1. Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M, Song XW, Xu H, Mari S, Qian F, Pei Y, Musco G, Boletta A: Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 19: 488–493, 2013. - PMC - PubMed
    1. Warner G, Hein KZ, Nin V, Edwards M, Chini CC, Hopp K, Harris PC, Torres VE, Chini EN: Food restriction ameliorates the development of polycystic kidney disease. J Am Soc Nephrol 27: 1437–1447, 2016. - PMC - PubMed
    1. Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M: Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease. J Am Soc Nephrol 29: 571–578, 2018. - PMC - PubMed

MeSH terms